1. MEN1 mutation
Multiple endocrine neoplasia type 1 is caused by mutations in the *MEN1* gene; approximately half of the patients develop pituitary tumors, most commonly prolactinomas or growth hormone-secreting tumors.
2. Hormonal imbalance
Prolonged estrogen stimulation can promote the proliferation of prolactin-secreting cells; an imbalance in the feedback regulation of target gland hormones is closely associated with the abnormal proliferation of pituitary cells.
3. Hypothalamic lesions
Hypothalamic inflammation or trauma disrupts regulatory signaling; excessive stimulation by factors such as growth hormone-releasing hormone (GHRH) can induce the development of specific types of pituitary tumors.
4. AIP mutation
Familial isolated pituitary adenoma is associated with *AIP* gene mutations; these are predominantly growth hormone-secreting adenomas characterized by early onset and large tumor size.
5. Carney complex
Carney complex, caused by *PRKAR1A* gene mutations, can be associated with pituitary growth hormone-secreting adenomas and follows an autosomal dominant inheritance pattern.
6. Radiation exposure
Exposure of the head to ionizing radiation may increase the risk of pituitary tumors, particularly by affecting the DNA repair mechanisms of pituitary cells.
7. Age and gender
Pituitary tumors are most common in individuals aged 20 to 50; prolactinomas are more frequent in women, whereas growth hormone-secreting tumors and non-functioning tumors are more common in men.
Conclusion
Pituitary tumors result from the interplay of various factors, such as genetic mutations and hormonal imbalances. Although mostly benign, they can severely impair endocrine function.Regular screening is crucial for individuals with a family history to ensure early detection and timely intervention.
